Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system.
about
Combating antimicrobial resistance: policy recommendations to save livesOutbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, MichiganBloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteriaAntimicrobial resistance in Acinetobacter baumannii: From bench to bedsideActive and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infectionBiology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment OptionsRapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data.Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.Colistin in the 21st century.Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin.Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii.Whole-genome sequence analysis of the naturally competent Acinetobacter baumannii clinical isolate A118Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii.genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii.Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.Combination approaches to combat multidrug-resistant bacteria.Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii.Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii.Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance.Diversity and evolution of AbaR genomic resistance islands in Acinetobacter baumannii strains of European clone I.The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A.Heteroresistance to colistin in Klebsiella pneumoniae associated with alterations in the PhoPQ regulatory system.Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria.Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogensPhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patientsIn Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic TreatmentPmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patientsThe Role of the Two-Component System BaeSR in Disposing Chemicals through Regulating Transporter Systems in Acinetobacter baumannii.A novel method of consensus pan-chromosome assembly and large-scale comparative analysis reveal the highly flexible pan-genome of Acinetobacter baumanniiThe Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosa.Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606.Cation concentration variability of four distinct Mueller-Hinton agar brands influences polymyxin B susceptibility results.In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.The polymyxin B-induced transcriptomic response of a clinical, multidrug-resistant Klebsiella pneumoniae involves multiple regulatory elements and intracellular targets.Effect of colistin exposure and growth phase on the surface properties of live Acinetobacter baumannii cells examined by atomic force microscopyCell surface hydrophobicity of colistin-susceptible vs resistant Acinetobacter baumannii determined by contact angles: methodological considerations and implications
P2860
Q24632857-D0F0779D-D506-4A63-9CB3-4DEBA28DB84BQ24633186-54E00EDB-B38D-4559-B955-A143B3D32D8BQ26795565-7592026C-2AB8-4D0A-A44C-FA6C0C23CD8EQ27024893-67460DCF-32A1-4704-B359-6748CB48C5ADQ28478751-E4D3EF7A-098F-44B6-B78A-1E91864A9DD3Q30235064-BC7FE5BA-156D-46A1-AA0C-9C13F09A76EFQ31031386-11AE3D4A-A83C-4594-AAC4-AF26776DFBA6Q33676136-78BB56F7-577A-47AC-84E6-8F3F45F230FFQ33847509-FFAF0366-AF66-46E5-A4ED-EF3343B6B2F1Q33901939-C950FC13-70EC-47FE-890D-E1FB10F348B6Q34058244-12D58E74-89AC-4034-A98F-AEDE29E25A0BQ34297656-3243FAD3-BF5D-4227-ADAD-656990D35B07Q34309451-EE35B912-C63E-4B9F-9D61-BEE56B2053CBQ34346016-79E46A21-2B39-4E78-80E4-55C04F839D50Q34366702-C8731FF7-52AB-49E3-8C66-2B439BFCA1C2Q34484474-8DD14CFC-14B0-4FED-A487-28E2E52577C9Q34508304-A49CEF49-E695-4D01-AE48-A77DFEEBBC19Q34552966-3763471B-F8CC-4929-94B0-5C495607261DQ34554879-E8ACC117-879F-47D3-AE6F-9EE3A330F06EQ34632985-88A0C84B-2582-46E8-8EC5-96C89CA7256BQ34764355-2C3A3CF3-B0F7-4C8C-97D7-7589EE727DC7Q34922881-C4975649-A4BB-4175-A736-D326AAD4BC52Q35065744-DF9296E8-2F1D-4DC1-84EE-50E72BA0A82FQ35139454-FD87989C-38D3-41AE-B4D2-1045C90EDE4FQ35385645-244DEE12-9744-47FF-A741-6D29DBD445DCQ35541353-E4842BC7-4637-4A09-AB90-3555774CBE61Q35561864-8C9D36D3-7C5A-4E70-A9A0-D42E23078B7BQ35598578-0CA066F2-3933-4877-A707-5D2A63BF44C5Q35662086-342DA4E0-CD3D-4AC0-B858-155EA98287C1Q35689189-74FED134-C959-4B1F-BDDF-B940BB93B6CAQ35841626-C5CC5F27-58A1-4996-B757-A4092DF2DAC4Q35865965-6908098B-AFF3-4909-AA99-6E33596507C1Q35905605-BB959D98-9327-4BE2-9EE9-4EAD7AEF256DQ36018883-F205A79B-F990-4837-B4F0-8F6BDAEAE5EEQ36104259-4EC57AA3-CD9F-41E9-9D40-3CB5386FD43BQ36118781-3E59B1D4-638B-4D09-A411-1E6379BAAF42Q36172548-81CADD7D-803A-4309-8552-0CC88C476EC9Q36179001-BE40572A-F378-444F-8B91-D50D1479935AQ36207747-C6AD8B35-FED6-49A5-B387-08AE3FC78777Q36210000-C038C8EE-568C-47D7-97C3-7170382460FF
P2860
Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Resistance to colistin in Acin ...... he PmrAB two-component system.
@en
Resistance to colistin in Acin ...... he PmrAB two-component system.
@nl
type
label
Resistance to colistin in Acin ...... he PmrAB two-component system.
@en
Resistance to colistin in Acin ...... he PmrAB two-component system.
@nl
prefLabel
Resistance to colistin in Acin ...... he PmrAB two-component system.
@en
Resistance to colistin in Acin ...... he PmrAB two-component system.
@nl
P2093
P2860
P356
P1476
Resistance to colistin in Acin ...... he PmrAB two-component system.
@en
P2093
A Rekha Murthy
Gabrielle C Nickel
Heather Lavender
Mark D Adams
Michael R Jacobs
Saralee Bajaksouzian
P2860
P304
P356
10.1128/AAC.00284-09
P407
P577
2009-06-15T00:00:00Z